In silico and pharmacokinetic studies of glucomoringin from Moringa oleifera root for Alzheimer's disease like pathology

References

• DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer's disease. Mol. Neurodegen. 14(1), 32 (2019).
   PubMed Web of Science ®Google Scholar
• Marco-Contelles J. Facts, results and perspectives of the current Alzheimer's disease research. ACS Chem. Neurosci. 10(3), 1127–1128 (2019).
   PubMed Web of Science ®Google Scholar
• Alzhiemer's Association Report. 2023 Alzheimer's disease facts and figures. Alzheimer's Dem. 19(4), 1598–1695 (2023).
   PubMed Web of Science ®Google Scholar
• Emma Nicholas. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 Lancet Public Health 7(2), 105–125 (2022).
   Web of Science ®Google Scholar
• Singh SK, Srivastav S, Castellani RJ, Plascencia-Villa G, Perry G. Neuroprotective and antioxidant effect of ginkgo biloba extract against AD and other neurological disorders. Neurotherapeutics 16(3), 666–674 (2019).
   PubMed Web of Science ®Google Scholar
• Nowak A, Kojder K, Zielonka-Brzezicka J et al. The use of ginkgo biloba L. as a neuroprotective agent in the Alzheimer's disease. Front. Pharmacol. 12, 775034 (2021).
   PubMed Web of Science ®Google Scholar
• Xie L, Zhu Q, Lu J. Can we use ginkgo biloba extract to treat Alzheimer's disease? lessons from preclinical and clinical studies. Cells 11(3), 1–26 (2022).
   Web of Science ®Google Scholar
• Chainoglou E, Hadjipavlou-Litina D. Curcumin in health and diseases: Alzheimer's disease and curcumin analogues, derivatives and hybrids. Int.J. Mol. Sci. 21(6), 1975 (2020).
   PubMed Web of Science ®Google Scholar
• Thota RN, Rosato JI, Dias CB, Burrows TL, Martins RN, Garg ML. Dietary supplementation with curcumin reduce circulating levels of glycogen synthase kinase-3β and islet amyloid polypeptide in adults with high risk of Type 2 diabetes and Alzheimer's disease. Nutrients 12(4), (2020).
   Web of Science ®Google Scholar
• Shabbir U, Rubab M, Tyagi A, Oh DH. Curcumin and its derivatives as theranostic agents in Alzheimer's disease: the implication of nanotechnology. Int.J. Mol. Sci. 22(1), 196 (2020).
   PubMed Web of Science ®Google Scholar
• Ruan Y, Xiong Y, Fang W et al. Highly sensitive Curcumin-conjugated nanotheranostic platform for detecting amyloid-beta plaques by magnetic resonance imaging and reversing cognitive deficits of Alzheimer's disease via NLRP3-inhibition. J. Nanobiotechnol. 20(1), 322 (2022).
   PubMed Web of Science ®Google Scholar
• Razgonova MP, Veselov VV, Zakharenko AM et al. Panax ginseng components and the pathogenesis of Alzheimer's disease (Review). Mol. Med. Reports 19(4), 2975–2998 (2019).
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhang Z, Liu J, Guo M, Li H. Panax Ginseng in the treatment of Alzheimer's disease and vascular dementia. J. Ginseng Res. 47(4), 506–514 (2023).
   PubMed Web of Science ®Google Scholar
• Li J, Huang Q, Chen J et al. Neuroprotective potentials of panax ginseng against Alzheimer's disease: a review of preclinical and clinical evidences. Front. Pharmacol. 12, 688490 (2021).
   PubMed Web of Science ®Google Scholar
• Huang X, Li N, Pu Y, Zhang T, Wang B. Neuroprotective effects of ginseng phytochemicals: recent perspectives. Molecules 24(16), 2939 (2019).
   PubMed Web of Science ®Google Scholar
• Friedli MJ, Inestrosa NC. Huperzine A and its neuroprotective molecular signaling in Alzheimer's disease. Molecules 26(21), 6531 (2021).
   PubMed Web of Science ®Google Scholar
• Villegas C, Perez R, Petiz LL, Glaser T, Ulrich H, Paz C. Ginkgolides and Huperzine A for complementary treatment of Alzheimer's disease. IUBMB Life 74(8), 763–779 (2022).
   PubMed Web of Science ®Google Scholar
• Gul A, Bakht J, Mehmood F. Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease. J. Chinese Med. Assoc. 82(1), 40–43 (2019).
   PubMed Web of Science ®Google Scholar
• Yan YP, Chen JY, Lu JH. Disease-modifying activity of Huperzine A on Alzheimer's disease: evidence from preclinical studies on rodent models. Int. J. Mol. Sci. 23(23), 15238 (2022).
   PubMed Web of Science ®Google Scholar
• Chatterjee P, Fernando M, Fernando B et al. Potential of coconut oil and medium chain triglycerides in the prevention and treatment of Alzheimer's disease. Mech. Ageing Dev. 186, 111209 (2020).
   PubMed Web of Science ®Google Scholar
• Wallace TC. Health effects of coconut oil-A narrative review of current evidence. J. Am. Coll. Nutr. 38(2), 97–107 (2019).
   PubMed Web of Science ®Google Scholar
• Ross SM. Coconut oil: effects of medium-chain triglycerides for prevention and treatment of Alzheimer disease. Holistic Nurs. Practice 35(1), 49–50 (2021).
   PubMed Web of Science ®Google Scholar
• Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front. Pharmacol. 4, 177 (2014).
   PubMed Web of Science ®Google Scholar
• Islam Z, Islam SMR, Hossen F, Mahtab-Ul-Islam K, Hasan MR, Karim R. Moringa oleifera is a prominent source of nutrients with potential health benefits. Int. J. Food Sci. 2021, 6627265 (2021).
   PubMedGoogle Scholar
• Vergara-Jimenez M, Almatrafi MM, Fernandez ML. Bioactive components in Moringa oleifera leaves protect against chronic disease. Antioxidants 6(4), (2017).
   Web of Science ®Google Scholar
• Abd Rani NZ, Husain K, Kumolosasi E. Moringa genus: a review of phytochemistry and pharmacology. Front. Pharmacol. 9, 108 (2018).
   PubMedGoogle Scholar
• Nwidu LL, Elmorsy E, Aprioku JS, Siminialayi I, Carter WG. In vitro anti-cholinesterase and antioxidant activity of extracts of Moringa oleifera plants from rivers state, Niger Delta, Nigeria. Medicines 5(3), 71 (2018).
   Google Scholar
• Azlan UK, Khairul Annuar NA, Mediani A et al. An insight into the neuroprotective and anti-neuroinflammatory effects and mechanisms of Moringa oleifera. Front. Pharmacol. 13, 1035220 (2022).
   PubMed Web of Science ®Google Scholar
• Mundkar M, Bijalwan A, Soni D, Kumar P. Neuroprotective potential of Moringa oleifera mediated by NF-kB/Nrf2/HO-1 signaling pathway: a review. J. Food Biochem. 46(12), e14451 (2022).
   PubMed Web of Science ®Google Scholar
• Griñán-Ferré C, Bellver-Sanchis A, Izquierdo V et al. The pleiotropic neuroprotective effects of resveratrol in cognitive decline and Alzheimer's disease pathology: from antioxidant to epigenetic therapy. Ag. Res. Rev. 67, 101271 (2021).
   PubMed Web of Science ®Google Scholar
• Wang C, Cai X, Hu W et al. Investigation of the neuroprotective effects of crocin via antioxidant activities in HT22 cells and in mice with Alzheimer's disease. Int. J. Mol. Med. 43(2), 956–966 (2019).
   PubMed Web of Science ®Google Scholar
• Hatziagapiou K, Kakouri E, Lambrou GI, Bethanis K, Tarantilis PA. Antioxidant properties of Crocus Sativus L. and its constituents and relevance to neurodegenerative diseases; focus on Alzheimer's and Parkinson's disease. Curr. Neuropharmacol. 17(4), 377–402 (2019).
   PubMed Web of Science ®Google Scholar
• Ozben T, Ozben S. Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease. Clin. Biochem. 72, 87–89 (2019).
   PubMed Web of Science ®Google Scholar
• Thakur S, Dhapola R, Sarma P, Medhi B, Reddy DH. Neuroinflammation in Alzheimer's disease: current progress in molecular signaling and therapeutics. Inflammation 46(1), 1–17 (2023).
   PubMed Web of Science ®Google Scholar
• Sung PS, Lin PY, Liu CH, Su HC, Tsai KJ. Neuroinflammation and neurogenesis in Alzheimer's disease and potential therapeutic approaches. Int. J. Mol. Sci. 21(3), 701 (2020).
   PubMed Web of Science ®Google Scholar
• Vlachakis D, Pavlopoulou A, Tsiliki G et al. An integrated in silico approach to design specific inhibitors targeting human poly(a)-specific ribonuclease. PLOS ONE 7(12), e51113 (2012).
   PubMed Web of Science ®Google Scholar
• Galati S, Di Stefano M, Martinelli E, Poli G, Tuccinardi T. Recent advances in in silico target fishing. Molecules 26(17), 5124 (2021).
   PubMed Web of Science ®Google Scholar
• Siva Kumar B, Anuragh S, Kammala AK, Ilango K. Computer aided drug design approach to screen phytoconstituents of Adhatoda vasica as potential inhibitors of SARS-CoV-2 main protease enzyme. Life 12(2), 315 (2022).
   PubMedGoogle Scholar
• Begum RF, Mohan S. Insights into vitamin E with combined oral contraceptive on INSR gene in PCOS by integrating in silico and in vivo approaches. Appl. Biochem. Biotechnol. doi: 10.1007/s12010-023-04710-8 (2023). ( Ahead of Print).
   PubMed Web of Science ®Google Scholar
• Singh SA, Vellapandian C. Structure of the blood brain barrier and its role in the transporters for the movement of substrates across the barriers. Curr. Drug Metabol. 24(4), 250–269 (2023). ( Ahead of Print).
   PubMed Web of Science ®Google Scholar
• Singh SA, Vellapandian CJFJoPS. The promising guide to LC–MS analysis and cholinesterase activity of Luffa cylindrica (L.) fruit using in vitro and in silico analyses. 9(1), 33 (2023).
   Google Scholar
• Agu PC, Afiukwa CA, Orji OU et al. Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Scient. Reports 13(1), 13398 (2023).
   PubMed Web of Science ®Google Scholar
• Bai G, Pan Y, Zhang Y et al. Research advances of molecular docking and molecular dynamic simulation in recognizing interaction between muscle proteins and exogenous additives. Food Chem. 429, 136836 (2023).
   PubMed Web of Science ®Google Scholar
• AS S, Vellapandian C. In silico and pharmacokinetic assessment of echinocystic acid effectiveness in Alzheimer's disease like pathology. 10(1), FSO904 (2023).
   Google Scholar
• Pires DE, Blundell TL, Ascher DB. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 58(9), 4066–4072 (2015).
   PubMed Web of Science ®Google Scholar
• Dulsat J, López-Nieto B, Estrada-Tejedor R, Borrell JI. Evaluation of free online ADMET tools for academic or small biotech environments. Molecules 28(2), (2023).
   PubMed Web of Science ®Google Scholar
• Abdul-Hammed M, Adedotun IO, Olajide M et al. Virtual screening, ADMET profiling, PASS prediction and bioactivity studies of potential inhibitory roles of alkaloids, phytosterols and flavonoids against COVID-19 main protease (M(pro)). Nat. Product Res. 36(12), 3110–3116 (2022).
   PubMed Web of Science ®Google Scholar
• Mortuza MG, Roni MAH, Kumer A et al. A computational study on selected alkaloids as SARS-CoV-2 Inhibitors: PASS prediction, molecular docking, ADMET Analysis, DFT and Molecular Dynamics Simulations. Biochem. Res. Int. 2023, 9975275 (2023).
   PubMed Web of Science ®Google Scholar
• Ramachandran B, Kesavan S, Rajkumar T. Molecular modeling and docking of small molecule inhibitors against NEK2. Bioinformation 12(2), 62–68 (2016).
   PubMedGoogle Scholar
• Zhang N, Gordon ML. Clinical efficacy and safety of donepezil in the treatment of Alzheimer's disease in Chinese patients. Clin. Interven. Aging 13, 1963–1970 (2018).
   PubMed Web of Science ®Google Scholar
• Birks JS, Harvey RJ. Donepezil for dementia due to Alzheimer's disease. Cochrane Datab. System. Rev. 6(6), Cd001190 (2018).
   PubMedGoogle Scholar
• Kim J, Lee HJ, Park SK et al. Donepezil regulates LPS and Aβ-stimulated neuroinflammation through MAPK/NLRP3 inflammasome/STAT3 signaling. Int. J. Mol. Sci. 22(19), 10637 (2021).
   PubMed Web of Science ®Google Scholar
• Hansen RA, Gartlehner G, Webb AP, Morgan LC, Moore CG, Jonas DE. Efficacy and safety of donepezil, galantamine and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. Clin. Interv. Aging 3(2), 211–225 (2008).
   PubMed Web of Science ®Google Scholar
• Saeedi M, Mehranfar F. Challenges and approaches of drugs such as memantine, donepezil, rivastigmine and aducanumab in the treatment, control and management of Alzheimer's disease. Rec. Pat. Biotechnol. 16(2), 102–121 (2022).
   PubMedGoogle Scholar
• Nguyen K, Hoffman H, Chakkamparambil B, Grossberg GT. Evaluation of rivastigmine in Alzheimer's disease. Neurodegen. Dis. Management 11(1), 35–48 (2021).
   PubMed Web of Science ®Google Scholar
• Birks JS, Grimley Evans J. Rivastigmine for Alzheimer's disease. Cochrane Datab. System. Rev. 10(4), Cd001191 (2015).
   Google Scholar
• Matsunaga S, Kishi T, Nomura I et al. The efficacy and safety of memantine for the treatment of Alzheimer's disease. Exp. Opin. Drug Saf. 17(10), 1053–1061 (2018).
   PubMed Web of Science ®Google Scholar
• Balázs N, Bereczki D, Kovács T. Cholinesterase inhibitors and memantine for the treatment of Alzheimer and non-Alzheimer dementias. Ideggyogyaszati Szemle 74(11–12), 379–387 (2021).
   PubMedGoogle Scholar
• Kishi T, Matsunaga S, Oya K, Nomura I, Ikuta T, Iwata N. Memantine for Alzheimer's disease: an updated systematic review and meta-analysis. J. Alzheimer's Dis. 60(2), 401–425 (2017).
   PubMed Web of Science ®Google Scholar
• Matsunaga S, Kishi T, Iwata N. Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis. PLOS ONE 10(4), e0123289 (2015).
   PubMed Web of Science ®Google Scholar
• Dou KX, Tan MS, Tan CC et al. Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer's disease: a network meta-analysis of 41 randomized controlled trials. Alzheimer's Res. Ther. 10(1), 126 (2018).
   PubMedGoogle Scholar
• Karim NA, Ibrahim MD, Kntayya SB, Rukayadi Y, Hamid HA, Razis AF. Moringa oleifera Lam: targeting chemoprevention. Asian Pacific J. Cancer Preven. 17(8), 3675–3686 (2016).
   PubMedGoogle Scholar
• Aliyu A, Shaari MR, Ahmad Sayuti NS et al. Moringa oleifera hydorethanolic leaf extract induced acute and sub-acute hepato-nephrotoxicity in female ICR-mice. Sci. Prog. 104(4), 368504211004272 (2021).
   PubMed Web of Science ®Google Scholar
• Rajan TS, Giacoppo S, Iori R et al. Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages. Fitoterapia 112, 104–115 (2016).
   PubMed Web of Science ®Google Scholar
• Xiong Y, Riaz Rajoka MS, Zhang M, He Z. Isolation and identification of two new compounds from the seeds of Moringa oleifera and their antiviral and anti-inflammatory activities. Nat. Product Res. 36(4), 974–983 (2022).
   PubMed Web of Science ®Google Scholar
• Yan G, Liping S, Yongliang Z. UPLC-Q-Orbitrap-MS(2) analysis of Moringa oleifera leaf extract and its antioxidant, antibacterial and anti-inflammatory activities. Nat. Product Res. 34(14), 2090–2094 (2020).
   PubMed Web of Science ®Google Scholar
• Galuppo M, Giacoppo S, De Nicola GR et al. Antiinflammatory activity of glucomoringin isothiocyanate in a mouse model of experimental autoimmune encephalomyelitis. Fitoterapia 95, 160–174 (2014).
   PubMed Web of Science ®Google Scholar